- Home
- PALI vs KAZR Comparison
PALI vs KAZR Comparison
Compare PALI & KAZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$1.51
N/A
Current Price
$2.30
Company Overview
Basic Information| Metric | PALI | KAZR |
|---|---|---|
| Founded | 1996 | 2024 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 359.0M | 398.1M |
| IPO Year | 2019 | 2024 |
Fundamental Metrics
Financial Performance| Metric | PALI | KAZR |
|---|---|---|
| Price | $1.51 | $2.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $10.22 | N/A |
| AVG Volume (30 Days) | ★ 3.5M | 335.4K |
| Earning Date | 11-09-2026 | 08-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.06 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $260,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1500.39 | N/A |
| 52 Week Low | $1.32 | $1.60 |
| 52 Week High | $2.86 | $3.20 |
Technical Indicators
Market Signals| Indicator | PALI | KAZR |
|---|---|---|
| Relative Strength Index (RSI) | 37.67 | 46.67 |
| Support Level | N/A | $1.71 |
| Resistance Level | $2.19 | $2.43 |
| Average True Range (ATR) | 0.13 | 0.28 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 24.31 | 42.96 |
Price Performance
Historical Comparison PALI
KAZR
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.